# Dewey Scientific

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dewey-scientific

- Industry: Biotechnology
- Headquarters: Pullman, US
- Website: www.deweyscientific.com
- Total disclosed funding: $3.2M
- Latest round: Series A (Aug 16, 2021)
- Investors on record: 1

## About

Dewey Scientific, LLC is a biotechnology firm dedicated to enhancing the cannabis industry through advanced genetic and agricultural solutions, providing cultivars that improve yield and crop resilience.Dewey Scientific, LLC was founded in 2018 in Pullman, US, specializing in the development of cannabis genetics. The company raised USD 3.2 mn in Series A funding on August 16, 2021, led by RIV Capital, marking its most recent investment. The founder, Jordan Zager, serves as the CEO and has a history of involvement in the cannabis sector.Dewey Scientific specializes in advancing the cannabis industry through innovative genetic and agricultural solutions. Core offerings include disease-resistant cultivars and high-yield genetics optimized for various cultivation methods, such as precision-tuned hydroponics and large-scale soil cultivation. The cultivars are bred to enhance sensory profiles, improving quality for consumers and cultivators alike. The company primarily serves commercial growers and businesses in North America and Europe.Dewey Scientific operates on a B2B revenue model, partnering with commercial growers and cannabis producers to enhance yield and product quality. Sales are conducted through direct contracts, offering bespoke genetics tailored to client needs. The flagship products, including disease-resistant cultivars, are sold on a per-unit basis, supporting large-scale cultivators. Revenue is further bolstered through long-term agreements that provide ongoing support and access to continuous research and development in cannabis genetics.In August 2021, Dewey Scientific, LLC raised USD 3.2 mn in Series A funding to acquire equipment and expand its genetics research and development. The company plans to launch new products aimed at improving cannabis cultivation and is targeting expansion into additional European markets by 2023. The funding will support these initiatives, enhancing their research capabilities and product offerings.

## Funding rounds

- Series A, Aug 16, 2021, $3.2M — RIV Capital

## Investors

- RIV Capital (https://capitalatlas.ai/funds/riv-capital) — Series A